|
Laxman Pai, Opalesque Asia: London-based Inflexion has held a GBP2.3 billion (around $3.1 billion) final close of its first-ever multi-asset continuation fund-the largest vehicle raised in Europe.
The Inflexion Continuation Fund I will provide four Inflexion portfolio companies with the opportunity to continue their ambitious growth plans with a particular focus on M&A, whilst providing existing Inflexion investors with significant liquidity together with the opportunity to re-invest, said a media release from European mid-market private equity firm.
The Fund consists of a diversified portfolio of global leaders and category champions across a broad range of resilient sectors, all well positioned to benefit from favourable market tailwinds, the release added.
The investments will follow Inflexion's repeatable and proven strategy for value creation, including ongoing international expansion, continued execution of organic growth initiatives, and M&A. A significant portion of the capital has been raised to support transformational M&A..
The four investments in the Fund are Aspen Pumps, Rosemont Pharmaceuticals, Ocorian, and CNX Therapeutics. "Aspen, Rosemont, Ocorian, and CNX all have clear growth strategies, and we are excited to continue to partner with them. In particular, there is a significant opportunity to turbocharge their growth through M&A," said Flor Kassai, Managing Partner at Inflexion.
The transaction provides existing Inflexion investors with...................... To view our full article Click here
|
RSS
